You are three weeks from signing an LOI, the quality of earnings looks clean, and the seller’s deck shows a sales machine that only needs capital to scale. The commercial diligence is where that story either survives contact with reality or quietly falls apart. Most deals do not die on the numbers. They underperform because the go-to-market engine that produced those numbers cannot be repeated, cannot be expanded, and cannot be handed to a new team without the founder’s rolodex. Go-to-market due diligence is the workstream that tells you which of those you are buying.
This guide is written for the operating partner scoping the commercial workstream and the portfolio-company executive who has to live with the answer. Not to explain what GTM diligence is, you already know, but to help you decide what evidence you actually need, who owns each finding, and how to judge the quality of the work before it lands in your investment committee memo. The difference between a good and a bad commercial diligence is rarely the length of the report. It is whether the report changes a number in the model or a line in the 100-day plan.
1. Start With the Decision, Not the Data Room
Commercial diligence goes wrong the moment it becomes a data-collection exercise. You get a 90-slide deck, a market-sizing appendix, and a competitive landscape that reads like a Wikipedia entry. None of it changes what you pay or how you operate. The discipline is to work backwards from the decisions the diligence must inform.
There are usually four:
- Do we proceed, and at what price? The commercial findings should either support the entry multiple or force a repricing conversation.
- What is the growth thesis, in mechanical terms? Not “we’ll grow the pipeline” but which channel, which segment, which motion produces the incremental revenue in the model.
- What breaks in the first year? Concentration, a key-person dependency, a channel that is already saturated, a CAC that is quietly rising.
- Who owns the fix, and by when? Every material commercial risk needs an owner and a place in the 100-day plan, or it is not diligence, it is trivia.
If a section of the diligence does not map to one of those four, ask why it is in the scope. Bain’s annual analysis of the private equity market has repeatedly pointed to the gap between deal theses that assume commercial upside and the operational capacity to deliver it. You can see the pattern across their Global Private Equity Report series: multiple expansion has done a lot of the heavy lifting in returns, and buyers who cannot underwrite genuine revenue growth are exposed when it stops.
So the first test of any go-to-market due diligence is simple. Show me the decision each finding informs. If the answer is “context,” cut it.
2. Separate the Market Story From the Company’s Actual Motion
Sellers conflate two things on purpose. The first is the market: how big it is, how fast it grows, how attractive the tailwinds look. The second is the company’s actual go-to-market motion: how this specific business acquires, converts, and retains customers today. A large, growing market means nothing if the company’s motion cannot capture it.
Good diligence keeps these separate and then tests the join between them. The market can be excellent and the motion can be broken. That is often the most interesting finding, because it means the upside is real but the value-creation work is heavier than the seller implied. It also means the price should reflect who is doing that work.
What to demand on the market side
You want a defensible bottom-up sizing tied to the company’s actual served segments, not a top-down TAM slide borrowed from an analyst. You want the growth rate sourced and dated. And you want the competitive set defined by who the company actually loses deals to, which you get from win/loss data, not from a magic quadrant. PitchBook and S&P Global Market Intelligence publish sector-level data that can sanity-check a market claim, and their research hubs (PitchBook, S&P Global Market Intelligence) are worth cross-referencing when a seller’s growth number looks generous.
What to demand on the motion side
This is the part sellers cannot dress up if you ask the right questions. How does a new customer actually enter the pipeline? What does the funnel look like stage by stage, with real conversion rates? What is the sales cycle, and is it lengthening? What percentage of new revenue comes from inbound versus outbound versus partner versus the founder personally closing it? The last one matters more than any market slide, because it tells you whether the motion survives the founder’s departure.
3. Interrogate Revenue Quality Before You Trust the Pipeline
The pipeline is a forecast. Revenue quality is a fact. Before you let anyone walk you through a weighted pipeline, understand the revenue you already have.
Three questions carry most of the weight:
- Concentration. What share of revenue sits in the top five and top ten customers? A business where the top three are 45 percent of revenue is a different asset than one where they are 12 percent, regardless of growth rate. Concentration is a discount, a covenant risk, and a 100-day priority all at once.
- Retention and expansion. Gross retention tells you whether the base leaks. Net retention tells you whether the base grows on its own. For recurring-revenue businesses, net revenue retention below 100 percent means the growth thesis is entirely dependent on new logos, which is a far more expensive and fragile way to grow.
- Cohort behavior. Are newer customer cohorts retaining and expanding as well as older ones, or worse? Declining cohort quality is the single most reliable early signal that a market is saturating or that the product has stopped fitting the customer.
This is where commercial diligence and the quality-of-earnings work overlap, and where they should be reconciled rather than run in parallel. If your QoE and your commercial team disagree on what counts as recurring revenue, you have found a problem worth chasing. Many of the same data hygiene issues that undermine a QoE also poison the pipeline analysis, and we walk through those in detail in data due diligence and the five data problems that survive a QoE. If the CRM data is dirty, every conversion rate in the report is fiction.
4. Find the Key-Person Dependency Before the Seller Names Their Price
The most expensive thing you can miss in a founder-led business is that the go-to-market motion is the founder. Not “the founder is involved in sales.” The founder personally sources, qualifies, negotiates, and closes the deals that matter, and no repeatable system exists underneath them.
You detect this by tracing specific deals. Take the ten largest wins of the last twelve months and ask who sourced each one, who ran it, and who signed it. If the founder or one or two star reps appear on most of them, you are not buying a sales engine. You are buying a relationship, and relationships do not transfer on a closing date.
This finding does not necessarily kill a deal. But it moves the value from realized to enabled, and it changes the 100-day plan from “scale the machine” to “build the machine first.” That is a materially different investment. Price it, resource it, and put it on the risk register with a named owner before you sign, not after the first board meeting when the founder announces a slower quarter.
5. Judge the Unit Economics That the Growth Thesis Assumes
Every growth thesis is an implicit bet on unit economics. If the thesis says “double the sales team and revenue follows,” it assumes the current cost to acquire a customer holds as you scale. It usually does not.
Three ratios you should not accept on faith:
Customer acquisition cost, fully loaded
Not just ad spend. Fully loaded CAC includes sales salaries, commissions, marketing headcount, and the tools that support them, divided by new customers won. A CAC that looks healthy on a marketing-only basis often looks alarming once you load in the sales org that actually closes the deals.
Payback period
How many months of gross margin does it take to recover the cost of acquiring a customer? A payback under twelve months gives you room to invest into growth. A payback stretching past twenty-four months means the growth thesis burns cash faster than it builds enterprise value, and the model needs to reflect that drag.
LTV to CAC, honestly calculated
The ratio is only as good as the retention assumption underneath the lifetime-value number. If the LTV assumes customers stay five years but the cohort data shows churn accelerating in year two, the ratio is inflated. Force the calculation back to observed retention, not aspirational retention.
The critical test is at the margin. The average CAC across the whole base tells you about the past. The CAC on the last incremental customers, and the trend in that number, tells you what scaling actually costs. If marginal CAC is rising, doubling the sales team does not double the revenue. It compresses the margin the whole thesis depends on.
6. Map the Channel and Whether It Has Room Left
A go-to-market motion that runs on a single channel is fragile in a way that averages hide. If 70 percent of new customers come from one paid channel, your growth is hostage to that channel’s cost and capacity. Two questions decide how much room the thesis has.
Is the primary channel saturating? Rising cost per lead, falling conversion, and a shrinking pool of net-new prospects all say the channel is maturing. You cannot buy your way out of a saturated channel, you can only pay more for the same result.
Is there a credible second channel? The strongest growth theses have a channel the company has not yet built out, with early evidence it works. The weakest ones assume the current channel scales linearly forever. When a company’s growth depends on standing up a channel it has never run, that is a build, not a lever, and builds carry execution risk that belongs in the model and in the plan.
This is also where the operating capability of the company matters. A motion that needs a new outbound engine, a partner program, or a marketing function that does not yet exist requires people and systems you will have to fund. That connects directly to how you staff the value-creation plan, which we cover in hiring a GTM strategy consultant for portfolio companies.
7. Check Whether the Systems Can Even Tell You the Truth
Everything above depends on data. Conversion rates, cohort retention, CAC by channel, none of it exists unless the company’s systems capture it cleanly. In a lot of lower-middle-market businesses, they do not.
The tell is simple: ask for the same number two ways and see if it matches. Ask finance for new-customer revenue by quarter, then ask the CRM for closed-won deals by quarter. If they do not reconcile, and often they do not, then every downstream metric is suspect and your commercial diligence is standing on sand.
This is where commercial and technology due diligence have to talk to each other. The commercial team needs the numbers; the tech team knows whether the numbers can be trusted. If the CRM is a graveyard of half-filled records, the fix is a first-100-days project, and the diligence should say so plainly. We have written about the mechanics of cleaning this up in CRM standardization across portfolio companies and in what private equity should ask a RevOps consultant.
The point for diligence is this: if the systems cannot produce the evidence, note that the commercial findings carry lower confidence, and carry a data-remediation line into the plan. Do not let a clean-looking report hide a dirty data layer.
8. Pressure-Test the Sales Team and the Comp That Drives It
The people who execute the motion are part of what you are buying. A diligence that never talks to a rep is missing the most direct read on whether the motion is repeatable.
Look at the distribution of quota attainment. If two reps carry the number and eight miss, the motion is not systematized, it is concentrated in a few individuals, and it will not scale by hiring more of the eight. Look at ramp time: how long before a new rep is productive? A six-month ramp caps how fast you can grow headcount, and that constraint belongs in the growth model.
Look at the compensation plan, because comp encodes what the company actually rewards. A plan that pays entirely on new logos with nothing on retention or expansion tells you why net revenue retention is weak. A plan that has not changed in three years tells you the company has not adjusted its motion to its market. These are fixable, but they are your fixes now, and they belong in the first-year plan.
9. Reconcile the Commercial Findings With the Model and the Plan
A commercial diligence that does not touch the model has failed, no matter how well written it is. The output that matters is a set of adjustments: to the revenue build, to the cost of growth, to the risk register, and to the 100-day plan.
Three reconciliations should happen before the report is final:
- Revenue build. Does the growth in the model come from channels and segments the diligence found to be real and scalable? If the model assumes 25 percent growth and the motion supports 12, the model changes or the price changes.
- Cost of growth. Does the operating model fund the CAC, the headcount, and the system fixes the growth actually requires? Growth that is unfunded in the model is not growth, it is a hope.
- Risk register. Does every material commercial finding, concentration, key-person dependency, channel saturation, dirty data, have an owner, a mitigation, and a place in the plan?
McKinsey’s work on private capital and value creation has consistently made the point that returns increasingly come from operational improvement rather than financial engineering, and you can trace that theme across their research on private markets. Commercial diligence is where you decide whether the operational improvement in your thesis is achievable, and whether you have priced the work to achieve it. BCG’s principal-investor research reaches a similar conclusion in its private equity practice: the value-creation plan has to be underwritten, not assumed.
10. Know Which Deal Type You Are Actually Running
The commercial diligence you need is not the same across deal types, and treating them the same is a common way to over-spend and under-inform.
In a growth-equity deal versus a control buyout, the weight of the diligence shifts. Growth equity lives or dies on whether the motion scales, so the channel and unit-economics work carries more weight. A buyout with a margin thesis may care more about concentration and retention. In a corporate carve-out, the hard question is whether the division’s go-to-market can even stand alone once the parent’s brand, shared sales force, and cross-sell go away. That is a very specific commercial risk that generic diligence misses entirely.
For an add-on, the commercial diligence has to test integration compatibility: do the two motions serve the same buyer, can the sales teams be merged, will the CRM systems reconcile? Many of those questions get harder the longer you hold the asset, which is why the burden increasingly sits with the operator rather than the deal team, a shift we have written about in how longer hold periods move the value-creation burden and in the context of GP-led continuation vehicles.
11. How to Judge the Diligence Itself
You are buying the diligence as much as you are buying the company. Bad commercial diligence is confident, comprehensive, and useless. Here is how to tell the difference before it goes in the IC memo.
Does it change a number?
The single best test. If the commercial report does not move a line in the model or the plan, it is a market summary, not diligence. Good work produces adjustments, not just observations.
Is the evidence primary?
Weak diligence recycles the seller’s deck and third-party market reports. Strong diligence rests on the company’s own data, customer interviews, win/loss analysis, and reference calls. When a claim rests on a secondary source, it should say so, and it should say how confident it is.
Does it name owners?
Every material risk should have a proposed owner and a home in the 100-day plan. A risk with no owner is a risk that will surface at the first board meeting instead of during diligence. Governance research from the Harvard Law School Forum on Corporate Governance and practitioner analysis in Harvard Business Review’s M&A coverage both reinforce a familiar point: the deals that disappoint are usually the ones where known risks had no accountable owner at close.
Does it distinguish realized from forecast?
The best commercial diligence is explicit about which value is already in the numbers, which is a reasonable forecast, and which depends on work you have not yet done. When a report presents enabled or forecast upside as though it were realized, that is not optimism, it is a category error, and it will cost you at the board table.
12. A Working Checklist for Your Commercial Diligence Scope
Use this to scope the workstream and to grade the output. If a section comes back thin, that is itself a finding.
- Decision map. Every workstream ties to proceed/price, growth thesis, first-year risk, or ownership. No orphan sections.
- Market vs motion. Bottom-up sizing on served segments. Funnel with real stage conversion. Revenue-source mix including founder-closed deals.
- Revenue quality. Top-5 and top-10 concentration. Gross and net retention. Cohort trend, newer versus older.
- Key-person risk. Trace the top ten wins. Who sourced, ran, and closed each. Named owner for the fix.
- Unit economics. Fully loaded CAC. Payback in months. LTV:CAC on observed retention. Marginal CAC trend.
- Channel. Concentration by channel. Saturation signals. Credible, evidenced second channel.
- Systems. CRM reconciles to finance. Confidence level flagged where it does not. Remediation line in the plan.
- Team and comp. Quota attainment distribution. Ramp time. Comp plan versus the motion you want.
- Reconciliation. Revenue build, cost of growth, and risk register all updated. Owners named. Plan tied to the first 100 days.
- Value classification. Every claim marked realized, run-rate, forecast, enabled, or risk avoided. No forecast dressed as realized.
The larger discipline behind all of this is treating private equity value creation as an operating problem you underwrite, not a narrative you accept. The seller’s job is to sell you a story. Your commercial diligence exists to find out which parts of it are true, which parts are your work to make true, and what that work costs. When it does that, it earns its fee many times over in a repricing avoided or a bad deal walked away from. When it does not, it is an expensive slide deck.
If you are scoping the commercial workstream on a live deal, or if a portfolio company’s growth is coming in under plan and you need to know whether the motion or the market is the problem, that is exactly the read a focused Commercial and GTM diligence is built to deliver.